Prolytix, formerly Haematologic Technologies, has 30+ years of experience solving protein chemistry challenges. With our comprehensive large-molecule analytical and bioanalytical services, coagulation expertise, and high-resolution mass spectrometry capabilities, we support projects from discovery through clinical/commercial release and stability. In addition, we provide research reagents and custom collection devices to academic institutions and other reasearch labs around the world.
Haematologic Technologies, Inc. (HTI) is a primary manufacturer of research reagents, specializing in the isolation and characterization of plasma proteins involved in the regulation of blood coagulation and fibrinolysis. Our product line of highly purified proteins includes zymogens, enzymes, cofactors, and inhibitors as well as monoclonal and polyclonal antibodies. Services available by contract include: ADA assay development and stability studies.